Your browser doesn't support javascript.
loading
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.
Wedeh, G; Cerny-Reiterer, S; Eisenwort, G; Herrmann, H; Blatt, K; Hadzijusufovic, E; Sadovnik, I; Müllauer, L; Schwaab, J; Hoffmann, T; Bradner, J E; Radia, D; Sperr, W R; Hoermann, G; Reiter, A; Horny, H-P; Zuber, J; Arock, M; Valent, P.
Affiliation
  • Wedeh G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Cerny-Reiterer S; LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, Cachan, France.
  • Eisenwort G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Herrmann H; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Blatt K; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Hadzijusufovic E; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Sadovnik I; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Müllauer L; Department of Radiotherapy, Medical University of Vienna, Vienna, Austria.
  • Schwaab J; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Hoffmann T; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Bradner JE; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Radia D; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sperr WR; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Hoermann G; Third Medical Department, Division of Hematology, University of Heidelberg, Mannheim, Germany.
  • Reiter A; Research Institute of Molecular Pathology (IMP), Vienna, Austria.
  • Horny HP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Zuber J; Guy's Hospital, Division of Clinical Haematology, London, UK.
  • Arock M; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Valent P; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
Leukemia ; 29(11): 2230-7, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26055303
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Nuclear Proteins / Leukemia, Mast-Cell / Epigenesis, Genetic Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Austria Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Nuclear Proteins / Leukemia, Mast-Cell / Epigenesis, Genetic Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Austria Country of publication: Reino Unido